Cargando…
A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer’s disease
Tauopathies, including Alzheimer’s disease (AD) and frontotemporal lobar degeneration with Tau pathology (FTLD-tau), are a group of neurodegenerative disorders characterized by Tau hyperphosphorylation. Post-translational modifications of Tau such as phosphorylation and truncation have been demonstr...
Autores principales: | García-Escudero, Vega, Ruiz-Gabarre, Daniel, Gargini, Ricardo, Pérez, Mar, García, Esther, Cuadros, Raquel, Hernández, Ivó H., Cabrera, Jorge R., García-Escudero, Ramón, Lucas, José J., Hernández, Félix, Ávila, Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217066/ https://www.ncbi.nlm.nih.gov/pubmed/33934221 http://dx.doi.org/10.1007/s00401-021-02317-z |
Ejemplares similares
-
Specific Peptide from the Novel W-Tau Isoform
Inhibits Tau and Amyloid β Peptide Aggregation In Vitro
por: Cuadros, Raquel, et al.
Publicado: (2022) -
p38 Inhibition Decreases Tau Toxicity in Microglia and Improves Their Phagocytic Function
por: Perea, Juan R., et al.
Publicado: (2022) -
Mouse and Human Tau Expression in Different Brain Areas
por: Vallés-Saiz, Laura, et al.
Publicado: (2022) -
Benefit of Oleuropein Aglycone for Alzheimer's Disease by Promoting Autophagy
por: Cordero, Joaquín G., et al.
Publicado: (2018) -
Tau Phosphorylation by GSK3 in Different Conditions
por: Avila, Jesús, et al.
Publicado: (2012)